Agricultural and Food Science, 17(4): 360-366, ISSN: 1459-6067
If a patient on a high dose of semaglutide cannot fill their prescription for a large injection pen, they may fear that they will have to go back to square one, the smallest starter dose, and lose months of progress
Side Effect Comparison Since both medications work through the same GLP-1 pathway, their side effect profiles are similar
Amp-activated protein kinase: a target for drugs both ancient and modern
Potential direct mechanisms involve GLP-1 receptor activation on vascular endothelial cells and possibly immune cells, though human evidence for the latter is variable
Heres how these options compare across both platforms: Note: Ozempic, Mounjaro, and meformin are not FDA-approved to treat obesity or for weight loss